Literature DB >> 31625057

Metabolic Syndrome, as Defined Based on Parameters Including Visceral Fat Area, Predicts Complications After Surgery for Rectal Cancer.

Chong-Jun Zhou1, Yi-Fan Cheng2, Lin-Zhen Xie2, Wan-Le Hu1, Bo Chen3, Lei Xu3, Chong-Jie Huang1, Mao Cai1, Xian Shen4,5, Chang-Bao Liu6.   

Abstract

BACKGROUND/
OBJECTIVES: Metabolic syndrome (MetS) has become a major public health problem. However, few studies have examined the impact of MetS on the postoperative complications of colorectal cancer and the conclusions remain controversial. The present study aimed to investigate whether MetS, as defined based on visceral fat area (VFA) instead of BMI or waist circumference, would predict complications after surgery for rectal cancer. SUBJECTS/
METHODS: We conducted a retrospective study of patients who underwent surgery for rectal cancer at our department between January 2013 and August 2018. Univariate and multivariate analyses evaluating the risk factors for postoperative complications were performed. A receiver operating characteristic curve analysis was used to determine the gender-specific cut-off values for VFA.
RESULTS: A total of 381 patients were included in the study. The optimal cut-off values for VFA were 117.9 cm2 for men and 76.9 cm2 for women, and 153 patients were diagnosed as having MetS. The rate of postoperative complication was significantly higher in the MetS group than that in the non-MetS group (34.6% versus 15.8%, P < 0.001). The multivariate logistic regression analysis demonstrated that MetS (OR 3.712, P < 0.001), NRS 2002 scores ≥ 3 (OR 2.563, P = 0.001), and tumor located at the lower 1/3 (OR 3.290, P = 0.001) were independent risk factors for complications after surgery for rectal cancer.
CONCLUSION: Metabolic syndrome, as defined based on parameters including visceral fat area, was an independent risk factor for complications after surgery for rectal cancer.

Entities:  

Keywords:  Metabolic syndrome; Postoperative complication; Rectal cancer; Visceral obesity

Year:  2020        PMID: 31625057     DOI: 10.1007/s11695-019-04163-1

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  35 in total

1.  The influence of metabolic syndrome in the outcomes of colorectal cancer patients.

Authors:  André Goulart; Ana Varejão; Fernanda Nogueira; Sandra Martins; António Mesquita-Rodrigues; Nuno Sousa; Pedro Leão
Journal:  Diabetes Metab Syndr       Date:  2017-07-08

2.  Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.

Authors:  Elizabeth M Cespedes Feliciano; Candyce H Kroenke; Jeffrey A Meyerhardt; Carla M Prado; Patrick T Bradshaw; Andrew J Dannenberg; Marilyn L Kwan; Jingjie Xiao; Charles Quesenberry; Erin K Weltzien; Adrienne L Castillo; Bette J Caan
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544

3.  In-Hospital Mortality and Post-Surgical Complications Among Cancer Patients with Metabolic Syndrome.

Authors:  Tomi Akinyemiju; Swati Sakhuja; Neomi Vin-Raviv
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 5.  Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.

Authors:  S O'Neill; L O'Driscoll
Journal:  Obes Rev       Date:  2014-11-18       Impact factor: 9.213

6.  Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome.

Authors:  F Cauchy; S Zalinski; S Dokmak; D Fuks; O Farges; L Castera; V Paradis; J Belghiti
Journal:  Br J Surg       Date:  2012-11-12       Impact factor: 6.939

7.  Metabolic syndrome and outcome after breast reconstruction.

Authors:  Areerat Ounhasuttiyanon; Visnu Lohsiriwat
Journal:  Gland Surg       Date:  2014-02

8.  Metabolic syndrome and breast cancer prognosis.

Authors:  Franco Berrino; Anna Villarini; Adele Traina; Bernardo Bonanni; Salvatore Panico; Maria Piera Mano; Angelica Mercandino; Rocco Galasso; Maggiorino Barbero; Milena Simeoni; Maria Chiara Bassi; Elena Consolaro; Harriet Johansson; Maurizio Zarcone; Eleonora Bruno; Giuliana Gargano; Elisabetta Venturelli; Patrizia Pasanisi
Journal:  Breast Cancer Res Treat       Date:  2014-08-08       Impact factor: 4.872

Review 9.  Nutritional Therapy in Gastrointestinal Cancers.

Authors:  Priscila Garla; Dan Linetzky Waitzberg; Alweyd Tesser
Journal:  Gastroenterol Clin North Am       Date:  2017-12-07       Impact factor: 3.806

10.  Cut-Off Values for Visceral Fat Area Identifying Korean Adults at Risk for Metabolic Syndrome.

Authors:  Arang Lee; Ye Ji Kim; Seung-Won Oh; Cheol Min Lee; Ho Chun Choi; Hee-Kyung Joh; Bumjo Oh; Seung-Sik Hwang; Seung Jae Kim; Oh Deog Kwon
Journal:  Korean J Fam Med       Date:  2018-07-04
View more
  7 in total

1.  The Association Between Metabolic Derangement and Wound Complications in Elective Plastic Surgery.

Authors:  Amanda R Sergesketter; Yisong Geng; Ronnie L Shammas; Gerald V Denis; Robin Bachelder; Scott T Hollenbeck
Journal:  J Surg Res       Date:  2022-05-16       Impact factor: 2.417

2.  Value of Visceral Fat Area in the Preoperative Discrimination of Peritoneal Metastasis from Gastric Cancer in Patients with Different Body Mass Index: A Prospective Study.

Authors:  He Huang; Xinxin Yang; Jing Sun; Ce Zhu; Xiang Wang; Yunpeng Zeng; Jingxuan Xu; Chenchen Mao; Xian Shen
Journal:  Cancer Manag Res       Date:  2020-07-28       Impact factor: 3.989

3.  BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy.

Authors:  Hengchang Liu; Ran Wei; Chunxiang Li; Zhixun Zhao; Xu Guan; Ming Yang; Zheng Liu; Xishan Wang; Zheng Jiang
Journal:  Cancer Manag Res       Date:  2020-10-20       Impact factor: 3.989

4.  Metabolic syndrome predicts postoperative complications after gastrectomy in gastric cancer patients: Development of an individualized usable nomogram and rating model.

Authors:  Xiaodong Chen; Weiteng Zhang; Xiangwei Sun; Mingming Shi; Libin Xu; Yiqi Cai; Wenjing Chen; Chenchen Mao; Xian Shen
Journal:  Cancer Med       Date:  2020-08-17       Impact factor: 4.452

5.  Obesity, Mediterranean Diet, and Public Health: A Vision of Obesity in the Mediterranean Context from a Sociocultural Perspective.

Authors:  Francesc Xavier Medina; Josep M Solé-Sedeno; Anna Bach-Faig; Alicia Aguilar-Martínez
Journal:  Int J Environ Res Public Health       Date:  2021-04-02       Impact factor: 3.390

Review 6.  Metabolic syndrome; associations with adverse outcome after colorectal surgery. A systematic review and meta-analysis.

Authors:  M Reudink; C D Slooter; L Janssen; A G Lieverse; R M H Roumen; G D Slooter
Journal:  Ann Med Surg (Lond)       Date:  2021-11-03

7.  Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy.

Authors:  Quoc Riccardo Bao; Filippo Crimì; Giovanni Valotto; Valentina Chiminazzo; Francesca Bergamo; Alessandra Anna Prete; Sara Galuppo; Badr El Khouzai; Emilio Quaia; Salvatore Pucciarelli; Emanuele Damiano Luca Urso
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.